Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest radiation therapy Stories

2013-12-19 23:02:05

A 33-year-old man from Leasburg, Mo., is the first patient to receive a revolutionary form of highly accurate radiation treatment from the world’s first proton system of its kind. The treatment was administered today at the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. St. Louis (PRWEB) December 19, 2013 A 33-year-old man from Leasburg, Mo., is the first patient to receive a revolutionary form of highly accurate...

2013-12-18 23:26:09

The rigor and standardization introduced into the radiology oncology practice at Memorial Cancer Institute following the LifeWings training, resulted in an increase in communication and teamwork that improved both safety and efficiency while improving both staff and patient satisfaction. Collierville, Tennessee (PRWEB) December 18, 2013 Communication patterns and protocol rigors of a methodology called crew resource management (CRM) can be adapted to a radiation oncology environment to...

2013-12-18 12:25:34

Agreement secures full Elekta solution across the McLaren enterprise ATLANTA, Dec. 18, 2013 /PRNewswire/ -- The ability to effectively manage data across disparate health systems to help drive quality care will be a cornerstone for health systems of the future. Elekta is proud to announce today that it has joined forces with Michigan-based McLaren Health Care to launch MOSAIQ® oncology information system throughout McLaren's cancer network. This partnership will enable McLaren to...

2013-12-18 11:17:57

Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International. The findings indicate the importance of monitoring patients for potential signs of bladder cancer to ensure early diagnosis and treatment. In the United States, uterine cancer is the fourth most common cancer in women, with an estimated 49,560 women diagnosed in 2013. In addition to surgery, 38 percent of...

2013-12-17 08:28:50

CLEVELAND, Dec. 17, 2013 /PRNewswire/ -- ViewRay(TM) Incorporated, a privately held medical device company, has secured $30 million in funding from existing equity investors, Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and OrbiMed Advisors, new investor, Cowealth Medical Holding Co Ltd (TT: 4745), as well as with debt financing provided by Hercules Technology Growth Capital (NYSE: HTGC), a Palo Alto-based specialty finance company whose focus is providing...

2013-12-15 23:00:29

In Response to Dr. Oz Dec, 6th Show on cell phone radiation causing breast cancer. RF Safe adds pink to the colors of their line of RF radiation shielded cell phone pouches for breast cancer awareness. Palo Alto, CA (PRWEB) December 15, 2013 Dr. Oz said women who keep their cell phones in their bras are putting themselves at risk for breast cancer. On the Dec. 6 episode of the Dr. Oz Show ("Why You Should Keep Your Cell Phone Out of Your Bra"), Dr. Oz said he believes...

2013-12-13 13:32:33

ESMO releases position paper on the role of medical oncologists in cancer care to ensure patient's access to optimal care Medical oncologists have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement from the European Society for Medical Oncology says. Medical oncologists are specialist cancer physicians trained to provide treatment with drugs, spanning from the old one-fits-all chemotherapy to newer targeted agents or...

2013-12-13 12:23:17

Data presented at the 2013 San Antonio Breast Cancer Symposium CLEVELAND, Dec. 13, 2013 /PRNewswire/ -- New research from University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University examined how changes in the genetic composition of breast cancer tumors after brief exposure to either biologic therapy or chemotherapy can predict future clinical outcomes in patients. Results showed that through deep...

2013-12-13 08:25:26

NEW YORK, Dec. 13, 2013 /PRNewswire/ -- The first Esteya® electronic brachytherapy system in the United States has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer treatment that relies on a small, high dose rate (HDR) X-ray source to apply high precision radiotherapy directly to the cancer site. "With support from Elekta, Memorial Sloan-Kettering will lead a multicenter clinical study...

2013-12-13 04:20:44

LUGANO, Switzerland, December 13, 2013 /PRNewswire/ -- ESMO releases position paper on medical oncologist's role Medical oncologists have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement from the European Society for Medical Oncology says [http://annonc.oxfordjournals.org/content/early/2013/12/13/annonc.mdt522.full.pdf+html ]. (Photo: http://photos.prnewswire.com/prnh/20131128/654773)...